<DOC>
	<DOC>NCT02835404</DOC>
	<brief_summary>The objective of this study was to evaluate the efficacy and complication of the treatment of pelvic external combined with 252-Cf neutron intracavitary radiotherapy with or without platinum in local advanced cervical cancer patients in the short and long term.</brief_summary>
	<brief_title>Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With or Without Platinum in Treating Advanced Cervical Cancer</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Nedaplatin</mesh_term>
	<criteria>1. To be aged from 18 (including 18) to 65 (including 65), female patient; 2. Expected survival ≥6 months 3. Pathologically proven diagnosis of squamous carcinoma or adenocarcinoma of the cervix, according to FIGO(International Federation of Gynecology and Obstetrics) staging, appropriate stage for protocol entry, including IIA2, IIB,IIIA,IIIB; 4. No patients with distant metastases; 5. Measurable target lesions (satisfying the criteria in RECIST 1.1); 6. ECOG PS status of 02; 7. No prior treatment; 8. No 9. No surgery 10. Major organ function has to meet the following criteria: 1. Bilirubin &lt;1.5 times the upper limit of normal (ULN) 2. ALT , AST and APL≤2.5 × ULN 3. NEUT≥2.0 × 10^9 / L 4. PLT ≥ 100 × 10^9 / L 5. HB≥60g/L 6. Serum Cr and urea nitrogen ≤ 1.5 × ULN 11. Favorable cardiac functions, no patients with myocardial infarction within half a year, hypertension and coronary disease are wellcontrolled. 1. Serious heart disease, pulmonary disease, hepatic disease, , renal disease and metabolic disease, or with electrolyte disturbance; 2. Allergic to platinum; 3. Rejecte to join the study in other conditions.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>